Raahil Chopra
Apr 29, 2021

Without digital, we wouldn’t be here even today: Albert Bourla, Pfizer

The chairman and CEO of Pfizer discusses his first reaction to the pandemic, how the company utilised digital to create the ‘impossible’ vaccine, and more…

Albert Bourla, Pfizer
Albert Bourla, Pfizer
Albert Bourla, chairman and CEO, Pfizer, was in conversation with Adobe’s chairman, president and CEO, Shantanu Narayen, during the virtual Adobe Summit held between 27-29 April.
 
The conversation kicked off with Narayen asking Bourla about his first reaction when he heard about the Covid-19 pandemic.
 
“Like everyone else, we heard about what was happening in China and thought it was a country-specific problem at first. However, it concerned us right from the beginning because we have large operations in China with thousands of people. We were concerned about their safety, and then about how the business would evolve,” he said.
 
Bourla stated that by the end of February, he was certain it was going to be a big issue for the world and wrote down three priorities.
 
“The first was the safety of the 90,000 people that were working with us. The second was that we had to also continue bringing in medicines that people would need during the pandemic. I was mainly concerned about hospitals because I knew that they would be overcrowded. The third was about what we can do to provide medical service. In my mind, the first one was treatment. It was within a week that I realised that we need to create a Covid vaccine,” he said.
 
Narayen then nudged Bourla to speak about how the company went about creating the vaccine in record time.
 
Bourla stated because everyone believed it was an impossible task, they went about the whole process very ‘differently’.
 
“Every time you are at the helm of a task like this, you need to think differently. The most important of all was that we had to deliver. This (different) thinking, was not only required at the top but had to be scaled down to every single person. To make the impossible possible, you need to have thousands of people believing that they can do it. We all believed it could happen. It was a glorious demonstration that people never know what they can or cannot do,” he said.
 
He added, “Luck never comes to the unprepared. This company was preparing for this moment. We had to build breakthroughs that would change. We were looking at changing the whole company. We significantly increased the investments in digital and research. We all know that we can’t transform a company by changing the business portfolio or by changing the location. You can only transform it by changing the culture. If we didn’t have the courage to think big, we wouldn’t think of manufacturing three billion doses. That’s how we found solutions.”
 
He added that the joy for Pfizer wasn’t from developing the vaccine, but the pride they got from belonging to a group that is solving purposes.
 
Then, amid the pandemic, and while the vaccine trials were in place, Pfizer rolled out its ‘Science Will Win’ campaign. Explaining this and the role of digital, Bourla, said, “At Pfizer, I was appointed CEO on 1 January. On the same day, we appointed a chief digital officer (CDO). That was the first signal sent in the organisation that digital will be the most important transformation tool at Pfizer. During this time, the first role the CDO received was to digitise our discovery and development process of medicines. For example, usually, we need four weeks to do specific processes in formulating the vaccines. By using advanced analytics, however, and a supercomputing platform, we were able to do it in 18 hours. The moment this study was completed, in two-three days (versus five-six months), we had the tables ready for submission. Without digital, we wouldn’t be here even today.”
 
The talk ended with Bourla touching upon the decision of Pfizer to undertake a rebranding exercise during the pandemic along with the importance of mission and purpose for companies.
 
Bourla explained, “We are very excited about initiating a new, transformed Pfizer that is much more focused on science than before. The science was far more patient-centric than before. When Pzifer’s name and reputation skyrocketed because of the work that we did with the vaccine, I thought it was the right time to launch the new identity, because we were doing this at a time of being in a position of strength.”
 
He added, “The brand mission guides everything we do. It’s very well-documented that corporations that stayed true to their mission and purpose, delivered way better than corporations that don’t. When you stay true to your purpose, you give good guidance to people on where they need to. But when your purpose is also so noble as in your case, your success is going to affect human lives. This is when it creates a passion and drive for each individual. The passion is what makes all the difference in the world.”
Source:
Campaign India

Related Articles

Just Published

14 hours ago

Amazon launches free video streaming service miniTV

The streaming service will be available of Amazon's shopping app

15 hours ago

Adlanders work long hours because clients don't pay ...

The D&AD chairman places the blame for adland's long-hours culture at the door of marketers

15 hours ago

Dentsu organic revenue declines 2.4% in 'encouraging...

Organic revenue fell 0.9% in Japan and 3.5% internationally in the first quarter, but overall underlying profit grew 20.8% as margins improved